Mitochondrial dysfunction and Alzheimer's disease: pathogenesis of mitochondrial transfer

Front Aging Neurosci. 2024 Dec 17:16:1517965. doi: 10.3389/fnagi.2024.1517965. eCollection 2024.

Abstract

In recent years, mitochondrial transfer has emerged as a universal phenomenon intertwined with various systemic physiological and pathological processes. Alzheimer's disease (AD) is a multifactorial disease, with mitochondrial dysfunction at its core. Although numerous studies have found evidence of mitochondrial transfer in AD models, the precise mechanisms remain unclear. Recent studies have revealed the dynamic transfer of mitochondria in Alzheimer's disease, not only between nerve cells and glial cells, but also between nerve cells and glial cells. In this review, we explore the pathways and mechanisms of mitochondrial transfer in Alzheimer's disease and how these transfer activities contribute to disease progression.

Keywords: AD treatment; Alzheimer’s disease; mitochondrial dysfunction; mitochondrial transfer; neuroprotection.

Publication types

  • Review

Grants and funding

The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. The authors gratefully acknowledge the financial support provided by the Beijing Natural Science Foundation Project (grant no. 7222297), Science and technology Innovation Project of China Academy of Chinese Medical Sciences (grant no. CI2021A01402), and the National Natural Science Foundation of China (grant nos. 81904194 and 82074509).